$SBH

Sally Beauty Holdings, Inc. (SBH): Results of Operations and Financial Condition

Sally Beauty Holdings, Inc. (SBH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991.htm EX-99.1 exhibit991 Contact: Jeff Harkins Investor Relations 940-297-4131 jharkins@sallybeauty.com Sally Beauty Holdings Reports Third Quarter Fiscal 2026 Results  Q3 Consolidated Net Sales Increased 0.2%; Consolidated Comparable Sales Flat  Q3 GAAP Dilu

Original reporting
Published Aug 3, 2026, 11:14 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 3, 2026, 11:33 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$SBH
Bullish
medium confidence
Mentioned
$SBH
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SBHBullishMed
01

Why it matters

Traders can update models for FY26 profitability and cash return based on the reported Q3 EPS/margins and the guidance narrowing, then reassess risk around flat comparable sales.

02

Market read

Q3 showed EPS and margin expansion alongside flat comparable sales, with management narrowing FY26 guidance ranges and continuing buybacks and debt repayment.

03

What to watch

Inventory is still large ($996M) and the company’s net debt leverage is 1.4x, which could constrain flexibility if demand softens.

Relevance 7/10Novelty 8/10Timing: today’s pre-market/filing earnings release and FY26 outlook update

Background

This is an SEC 8-K (Item 2.02) with Q3 FY26 results and an updated full-year guidance range for Sally Beauty Holdings.

Company-level read

Ticker impact

$SBHBullishMedium confidence
Context

Sally Beauty reported Q3 FY26 net sales up 0.2% and GAAP diluted EPS up 25%, plus narrowed FY26 outlook within prior guidance ranges.

Expected impact

Likely modest positive bias if the market focuses on EPS growth, margin expansion, and buyback/term-loan repayment, with upside capped by flat comparable sales.

Evidence & confidence

EPS and margin expanded while comparable sales were flat; the company also narrowed guidance within prior ranges, which typically limits surprise but can still reinforce confidence in earnings quality and capital allocation.

Market effects

Adds another datapoint on discretionary retail and beauty supply demand, with emphasis on e-commerce growth and hair-color strength.

Highlights strength in Sally U.S. and Canada comparable sales, which can influence regional sentiment for specialty retail.

Global e-commerce growth and margin expansion provide signals for international channel mix and cost discipline.

Counterpoint

Flat consolidated comparable sales and only guidance narrowing within prior ranges suggest limited incremental upside versus expectations.

Key entities

  • Sally Beauty Holdings, Inc.

    Reported Q3 FY26 results, cash flow, capital allocation (term loan repayment and share repurchases), and narrowed FY26 guidance within prior ranges.

  • Denise Paulonis

    CEO quoted on progress against long-term strategy and strategic initiatives driving EPS growth and cash flow.

Related articles

$SBHMed

Why Sally Beauty Stock Popped Today

Sally Beauty Holdings (SBH) shares rose after the company reported fiscal Q3 ended June 30. Net sales rose 0.2% to $935 million, comparable store sales increased 1.6%, and e-commerce sales grew 11% to $110 million. Adjusted net earnings rose 4% to $54 million, EPS rose 8% to $0.55, and free cash flow was $62 million. Full-year outlook: sales ~$3.7B, EPS $2.04 to $2.08.

$SBHMedAI 8/10

Sally Beauty Q3 Earnings Call Highlights

Sally Beauty Holdings (NYSE:SBH) reported Q3 net sales of $397 million for Beauty Systems Group, down 2.4% Y/Y, with comparable sales down 2.1%. Adjusted gross margin rose to 52.4% and Fuel for Growth savings totaled $9 million. FY2026 outlook narrowed to net sales $3.725B-$3.733B and adjusted EPS $2.04-$2.08.

$DTMedAI 8/10

Dynatrace Springs on Q1 Figures

Dynatrace (NYSE: DT) reported Q1 FY2027 results for the quarter ended June 30, 2026. Total ARR was $2,136 million, up 17%. Total revenue rose to $555 million, up 16%. Subscription revenue was $530 million. GAAP operating income was $71 million and non-GAAP $162 million. CEO Rick McConnell cited 41% organic net new ARR growth and accelerating TTM growth.

$DBXMed

Dropbox Shares Decline Despite Earnings Beat as Revenue Growth Disappoints

Dropbox (DBX) shares fell about 5% premarket to around $32.80 after Q2 2026 results. The company reported adjusted EPS of $0.75 vs $0.74 expected and revenue of $631.5M vs about $627M, but revenue rose only 0.9% year over year. Non-GAAP operating margin improved to 39.7%. Paying users reached 18.19M. William Blair upgraded to Market Perform, while consensus remains Sell.

$HLMedAI 8/10

Hecla Mining Q2 Earnings Call Highlights

Hecla Mining reported Q2 financial and operating updates. The company ended the quarter with $483 million cash, about $472 million net cash, and an essentially undrawn $225 million revolver. It projected 2026 free cash flow of about $500 million at $50 silver and $3,500 gold, and raised Greens Creek silver guidance to 8.0-8.3 million ounces. Production guidance was adjusted for Lucky Friday and Keno Hill.

$RCELHighAI 9/10

Avita Medical Shares Surge After Record Second-Quarter Performance

Avita Medical (NASDAQ:RCEL) shares rose about 21.7% in premarket after it reported record Q2 results. Revenue was $21.7M, up 18% YoY and about 8% above estimates. Adjusted loss per share narrowed to $0.25 vs $0.30 expected. Full-year 2026 revenue guidance raised to $86M-$89M and cash-flow breakeven targeted for Q4 2026. BTIG upgraded to Buy with a $7.00 target.